i
Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States
-
April 22, 2023
Details:
-
Corporate Authors:
-
Subjects:
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type: